The Lancet Oncology: UN officials warn refugees are struggling to access cancer treatment

(The Lancet) A study published in The Lancet Oncology journal reveals a high demand for costly cancer treatment among refugees from the recent conflicts in Iraq and Syria, with host countries struggling to find the money and the medicine to treat their new patients. The findings have prompted calls from lead author Dr. Paul Spiegel, the United Nations High Commissioner for Refugees Chief Medical Expert, for innovative financing schemes to improve access to affordable high-quality cancer care for...